Focus Stocks
Unum Group Declares Quarterly Dividend of 10.5 cents Per Share of its Common Stock
Published on Tuesday, 17 January 2012 08:09 Written by TradersHuddle Staff
CHATTANOOGA, Tenn.-( Business Wire )-Effective Jan. 16, 2012, the Unum Group (NYSE:UNM) Board of Directors declared a quarterly dividend of 10.5 cents per share on its common stock to be paid on Feb. 17, 2012, to stockholders of record on Jan. 30, 2012.
ABOUT UNUM
Unum (www.unum.com) is one of the leading providers of employee benefits products and services and the largest provider of group and individual disability income protection insurance in the United States and the United Kingdom.
Related Articles
- Get Benefit Smart: New site cuts through the insurance jargon
- Garofalo moves into top HR role at Unum, Farrar announces retirement
- Cancer, pregnancy continue to lead disability causes for Unum
- Colonial Life Launches New Group Term Life Product
- Unum Group’s Board of Directors Votes to Increase Common Stock Dividend
- Unum Group Reports First Quarter 2012 Results
- National Survey Reveals Important Income Protection Needs, and Opportunities, for Employees and Their Families
- Unum Group declares quarterly dividend of 10.5 cents per share of its common stock
- CORRECTING and REPLACING Unum Group to release first quarter 2012 results and host conference call
- Unum Group to release first quarter 2012 results and host conference call
Related Partner Headlines
- Unum Group Increases Dividend by 23.8% to $0.13 - Benzinga
- Unum Group Stock To Go Ex-dividend Tomorrow (UNM) - TheStreet.com
- UPDATE: Bank of America Raises Unum Group's PT - Benzinga
- UPDATE: J.P. Morgan Upgrades Unum to Overweight - Benzinga
- Work Till You Drop: A Sincere Revaluation of Retirement in America - Benzinga
- Unum Group Beats Q4 EPS Estimates - Benzinga
- Unum Group Stock To Go Ex-dividend Tomorrow (UNM) - TheStreet.com
- Unum Group Stock To Go Ex-dividend Tomorrow (UNM) - TheStreet.com
- Unum Group (UNM): Today's Featured Insurance Winner - TheStreet.com
What’s the next under-$10 stock that could be ready to skyrocket? Find out now when you join David Peltier at Stocks Under $10.
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Status Quo Is Good for Germany - TheStreet.com -
A Greek Exit Would Cut Both Ways - TheStreet.com -
Juniper Networks Inc. (JNPR): Today's Featured Technology Loser - TheStreet.com -
Celgene Corporation (CELG): Today's Featured Health Care Loser - TheStreet.com -
Colgate-Palmolive Company (CL): Today's Featured Consumer Goods Loser - TheStreet.com -
Virgin Media Inc (VMED): Today's Featured Services Loser - TheStreet.com -
Red Hat Inc. (RHT): Today's Featured Computer Software & Services Loser - TheStreet.com -
Royal Dutch Shell PLC ADR (RDS.B): Today's Featured Basic Materials Loser - TheStreet.com
Stock Market
Loading
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,496.15 Trade time:4:05PM EDT Value change:▼6.66 (-0.05%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,318.86 Trade time:4:33PM EDT Value change:▲2.23 (0.17%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,850.12 Trade time:5:16PM EDT Value change:▲11.04 (0.39%)In The Wires
-
Every Day is Memorial Day for Bugles Across America -
SBS Entertainment, MegaTV and Puerto Rico Tourism Company Present "Encanto del Caribe" with Arthur Hanlon and friends from the San Cristobal Fort in San Juan, Puerto Rico today Wednesday, May 23, at 8pm (ET)- 7pm (CT) on MegaTV -
New York Mortgage Trust Arranges Long Term Financing Secured by Multifamily CMBS Assets -
Coastal to Present at 9th Annual Craig-Hallum Institutional Investor Conference -
Klahoose First Nation and Alterra Power Sign Agreement for Upper Toba Project -
Robert A. Iger, Chairman and Chief Executive Officer, The Walt Disney Company, To Speak at the Sanford C. Bernstein Annual Strategic Decisions Conference 2012 -
CME Group Inc. Announces Preliminary Results from its 2012 Annual Meeting of Shareholders -
HeartWare Announces Publication Of Results From U.S. Bridge-To-Transplant Clinical Trial









